300255.SZ
Price:
$40.41
Market Cap:
$37.14B
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.
Industry
Biotechnology
IPO Date
2011-08-19
Stock Exchange
SHZ
Ticker
300255.SZ
According to Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.29B. This represents a change of -14.51% compared to the average of 45.95B of the last 4 quarters.
The mean historical Enterprise Value of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. over the last ten years is 13.48B. The current 39.29B Enterprise Value has changed 29.04% with respect to the historical average. Over the past ten years (40 quarters), 300255.SZ's Enterprise Value was at its highest in in the December 2025 quarter at 58.75B. The Enterprise Value was at its lowest in in the December 2018 quarter at 3.55B.
Average
13.48B
Median
6.62B
Minimum
3.71B
Maximum
58.76B
Discovering the peaks and valleys of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 197.01%
Maximum Annual Enterprise Value = 58.76B
Minimum Annual Increase = -36.87%
Minimum Annual Enterprise Value = 3.71B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 58.76B | 197.01% |
| 2024 | 19.79B | 46.98% |
| 2023 | 13.46B | 112.36% |
| 2022 | 6.34B | -25.37% |
| 2021 | 8.49B | 30.82% |
| 2020 | 6.49B | 26.29% |
| 2019 | 5.14B | 38.46% |
| 2018 | 3.71B | -36.87% |
| 2017 | 5.88B | -12.93% |
| 2016 | 6.75B | -21.97% |
The current Enterprise Value of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
30.67B
5-year avg
21.37B
10-year avg
13.48B
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s Enterprise Value is less than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (46.30B), less than Haisco Pharmaceutical Group Co., Ltd. (58.89B), less than RemeGen Co Ltd (65.53B), less than Shenzhen Salubris Pharmaceuticals Co., Ltd. (39.68B), less than Pharmaron Beijing Co., Ltd. (44.12B), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (38.95B), less than Shanghai Allist Pharmaceuticals Co., Ltd. (40.93B), less than Chongqing Zhifei Biological Products Co., Ltd. (44.88B), less than Shanghai Pharmaceuticals Holding Co., Ltd (93.04B), greater than Shanghai RAAS Blood Products Co., Ltd. (37.58B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 46.30B | $48.29B | |
| 58.89B | $58.46B | |
| 65.53B | $64.56B | |
| 39.68B | $40.09B | |
| 44.12B | $39.40B | |
| 38.95B | $39.24B | |
| 40.93B | $42.27B | |
| 44.88B | $35.28B | |
| 93.04B | $61.63B | |
| 37.58B | $35.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hebei Changshan Biochemical Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hebei Changshan Biochemical Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)?
What is the 3-year average Enterprise Value for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)?
What is the 5-year average Enterprise Value for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)?
How does the current Enterprise Value for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) compare to its historical average?